![]() |
市场调查报告书
商品编码
1828124
2025年高流量通风设备全球市场报告High Flow Ventilators Global Market Report 2025 |
近年来,高流量通气市场规模强劲成长,从2024年的339.7亿美元成长至2025年的367.7亿美元,复合年增长率为8.2%。预测期内的增长归因于监测和控制系统的改进、老年人口的增长、家庭医疗保健的扩展、急救护理的需求以及术后护理的应用。
预计未来几年高流量通气市场将快速成长,到2029年将达到572.7亿美元,复合年增长率为11.7%。预测期内的成长可归因于对非侵入性通气的关注、新生儿和儿科护理的需求、加湿系统的改进、家庭医疗保健环境的扩展以及急救护理的使用。预测期内的主要趋势包括客製化和多功能性、注重患者舒适度、整合监测技术、家用高流量通气以及在重症监护环境中的应用。
高流量呼吸器是一种呼吸支持方式,它以比传统氧气疗法更高的流速输送湿化氧气。这类呼吸器通常用于治疗呼吸器相关疾病(例如慢性阻塞性肺病))的患者。
高流量呼吸器的主要类型包括可携式高流量呼吸器和推车式高流量呼吸器。可携式高流量呼吸器是医疗设备,旨在为需要呼吸辅助的患者提供高流量氧气疗法。这类呼吸机使用各种接口,包括有创和非有创接口,广泛应用于医院、门诊手术中心、专科诊所、长期护理中心和其他医疗机构。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供高流量通风设备市场统计数据,例如全球市场规模、区域份额、高流量通风设备市场份额的竞争对手、详细的高流量通风设备细分市场、市场趋势和商机,以及您在高流量通风设备行业取得成功所需的数据。这份高流量通风设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
我们预测未来五年该市场将成长11.7%,较我们先前对该市场的预测略有下降0.3%。下降的主要原因是美国与其他国家之间的关税影响。这将透过对来自奥地利和巴西等主要地区的涡轮流量发电机和先进加湿系统征收关税直接影响美国,从而可能导致重症监护室(ICU)的通气能力下降,并增加急性呼吸机护理的成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛地显现。
慢性阻塞性肺病(COPD) 盛行率的预期成长预计将推动高流量呼吸器市场的未来成长。 COPD 是一种慢性发炎性肺部疾病,会对呼吸系统造成挑战,其特征是不可逆的气流受限,通常会随着时间的推移而发展。高流量呼吸器透过促进氧合、减少呼吸负荷和提供吐气末正压在 COPD 管理中发挥关键作用,特别是在病情恶化或需要高级呼吸支持时。截至 2023 年 3 月,苏格兰公共卫生观察站的数据显示 COPD 盛行率不断上升,男性(每 100,000 例新病例从 83.2 例增至 97.6 例)和女性(每 100,000 例新病例从 72.6 例增至 97.3 例增至 97.3 财年这一上升趋势是在 COVID-19 影响缓解之后出现的,表明 COPD 盛行率的上升将推动高流量呼吸机市场的成长。
预计老龄化人口的增加将促进高流量呼吸器市场的成长。老化是指社会中老年人比例随时间推移不断增加的人口结构变化。高流量呼吸器为老年人提供非侵入性呼吸支持,解决与老龄化相关的呼吸问题,同时提高舒适度和适应性。根据世界卫生组织 (WHO) 2022 年 10 月的预测,到 2030 年,全球六分之一的人将年龄在 60 岁或以上。在此期间,60 岁或以上人口的比例预计将从 2020 年的 10 亿增加到 14 亿。此外,预计到 2050 年全球 60 岁或以上人口将翻一番,达到 21 亿。因此,老化人口的增加是高流量呼吸器市场的主要驱动力。
高流量呼吸器市场的主要企业正致力于开发先进的高流量氧气疗法呼吸机,以改善患者照护、简化呼吸支援并满足医疗环境中对多功能、易用设备日益增长的需求。先进的高流量氧气疗法呼吸机是专门为患者输送大量氧气的机器,可改善氧合和呼吸支持,特别是在急性呼吸衰竭或重症通气的情况下。例如,美国医疗技术公司 Nihon Kohden America, Inc. 于 2024 年 10 月推出了 NKV-440。该系统旨在解决人员短缺和预算限制等医疗保健挑战,同时为医疗保健专业人员提供广泛可用的可靠呼吸解决方案。该创新系统旨在满足当今医疗环境中对灵活呼吸器日益增长的需求。
高流量呼吸器市场的主要企业正致力于打造创新解决方案,例如湿化高流量治疗,以提升患者舒适度、改善呼吸预后,并提供多样化的治疗方案,满足各种患者的需求。湿高流量治疗以高流量输送温暖湿润的空气或氧气,透过降低气道阻力和防止干燥来改善舒适度并支持肺功能。加热湿化技术为输送给患者的空气增加水分,保持呼吸道湿润,进一步改善舒适度和呼吸功能。例如,2024年8月,总部位于纽西兰的医疗科技公司Fisher & Paykel Healthcare Corporation推出了F&P my820系统,旨在改善居家呼吸照护。该系统旨在改善非院内机械通气患者的照护和预后,满足医疗机构外日益增长的有效呼吸支持需求。其主要目的是为成人和儿科患者提供高品质的加热湿化,确保他们即使出院后也能继续获得有效的呼吸照护。
2022年9月,总部位于瑞士的非侵入式监测解决方案提供商Sentec完成了对Percussionaire的收购,收购金额未揭露。此次收购使Sentec能够透过整合Percussionaire的TRUE-IPV技术来扩展其呼吸监测产品线。 Percussionaire是一家总部位于美国的专业呼吸机公司,专注于呼吸护理产品的开发、製造和行销,包括流量辅助呼吸器。
高流量呼吸器市场的主要企业包括 ResMed Inc.、Hamilton Medical AG、Hersill SL、ZOLL Medical Corporation、Percussionaire Corporation、Vyaire Medical Inc.、Koninklijke Philips NV、Medtronic Plc、Acutronic Medical Systems AG、Essexkel Inc.、Getinge AB、Drager KAGsher & Healthcare & IT、Ysher & Co.Ltd.、Intersurgical Ltd.、Laerdal Medical AS、Magnamed Tecnologia Medica SA、Medin Medical Innovations GmbH、Mercury Medical LLC、Mindray Medical International Limited、Nihon Kohden Corporation、O-Two Medical Technologies Inc.、Pululyne Systems Inc.、Sechrist Industries Inc.Sunc.S.S. Inc.、威海壮医科技有限公司和 Westmed Inc.
2024年,北美是高流量通风设备市场最大的地区。根据全球高流量通风设备市场报告,预计亚太地区在预测期内将成为成长最快的地区。高流量通风设备市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。
高流量通风设备市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
高流量呼吸器市场涵盖高流量呼吸器、加湿系统、氧气鼻管、呼吸管路和过滤器的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
High flow ventilators are a form of respiratory support that delivers humidified oxygen at a flow rate higher than traditional oxygen therapy. These ventilators are commonly utilized in the treatment of patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD) and other respiratory ailments.
The main types of high flow ventilators include portable high flow ventilators and trolley-mounted high flow ventilators. Portable high-flow ventilators are medical devices designed to administer high-flow oxygen therapy to patients in need of respiratory assistance. These ventilators use various interfaces, both invasive and non-invasive, and find applications in hospitals, ambulatory surgical centers, specialty clinics, long-term care centers, and other healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The high flow ventilators market research report is one of a series of new reports from The Business Research Company that provides high flow ventilators market statistics, including high flow ventilators industry global market size, regional shares, competitors with a high flow ventilators market share, detailed high flow ventilators market segments, market trends and opportunities, and any further data you may need to thrive in the high flow ventilators industry. This high flow ventilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The high flow ventilators market size has grown strongly in recent years. It will grow from $33.97 billion in 2024 to $36.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to enhanced monitoring and control systems, a growing geriatric population, expansion in home healthcare, demand in emergency medicine, and applications in postoperative care.
The high flow ventilators market size is expected to see rapid growth in the next few years. It will grow to $57.27 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to a focus on non-invasive ventilation, neonatal and pediatric care demand, improved humidification systems, expansion in home healthcare settings, and emergency medicine utilization. Major trends in the forecast period include customization and versatility, focus on patient comfort, integration of monitoring technology, home-based high-flow ventilation, and adoption in critical care settings.
The forecast of 11.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on turbine flow generators and advanced humidification systems, sourced from key regions such as Austria and Brazil, which could lead to reduced ICU ventilation capacity and increased costs for acute respiratory care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in the prevalence of chronic obstructive pulmonary disease (COPD) is set to drive the growth of the high-flow ventilators market in the future. COPD, a chronic inflammatory lung disease, poses challenges to breathing and is characterized by irreversible airflow limitation that typically progresses over time. High-flow ventilators play a crucial role in COPD management by enhancing oxygenation, reducing the workload of breathing, and offering positive end-expiratory pressure, particularly during exacerbations or instances requiring advanced respiratory support. As of March 2023, data from the Scottish Public Health Observatory revealed a rise in COPD rates, with an upward trend seen in both males (from 83.2 to 97.6 cases per 100,000 new cases) and females (from 72.6 to 97.3) for the financial year 2021 to 2022. This upward trend follows the easing of the COVID-19 impact, indicating that the increasing prevalence of COPD will be a driving force for the growth of the high-flow ventilators market.
The increasing aging population is expected to contribute to the growth of the high-flow ventilators market. An aging population refers to a demographic shift characterized by a rising proportion of elderly individuals within a society over time. High-flow ventilators offer non-invasive respiratory support for elderly individuals, addressing age-related respiratory challenges with enhanced comfort and adaptability. According to the World Health Organization's October 2022 projections, by the year 2030, 1 out of every 6 individuals globally will be 60 years old or older. During this period, the proportion of the population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion. Moreover, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion by the year 2050. Thus, the rising aging population is a significant driver for the high-flow ventilators market.
Leading companies in the high-flow ventilator market are focusing on the development of advanced high-flow oxygen therapy ventilators to improve patient care, enhance respiratory support efficiency, and cater to the rising demand for versatile and user-friendly devices in healthcare environments. Advanced high-flow oxygen therapy ventilators are specialized machines that provide a greater flow of oxygen to patients, thereby improving oxygenation and respiratory support, especially in cases of acute respiratory failure or situations that require enhanced ventilation. For example, in October 2024, Nihon Kohden America, a medical technology firm based in the US, launched the NKV-440, which aims to tackle healthcare challenges such as staffing shortages and budget limitations while ensuring broader access to dependable respiratory solutions for healthcare providers. This innovative system is designed to meet the increasing demand for flexible ventilators in the current healthcare landscape.
Key players in the high-flow ventilator market are focusing on creating innovative solutions, such as humidified high-flow therapies, to improve patient comfort, enhance respiratory outcomes, and offer versatile treatment options for various patient needs. Humidified high-flow therapies deliver warm, moist air or oxygen at higher flow rates, which enhances comfort and supports lung function by reducing airway resistance and preventing dryness. Heated humidification adds moisture to the air provided to patients, further improving comfort and respiratory function by keeping airways moist. For example, in August 2024, Fisher & Paykel Healthcare Corporation, a medical technology company based in New Zealand, introduced the F&P my820 System, designed to improve respiratory care at home. This system aims to enhance care and outcomes for patients receiving mechanical ventilation in non-hospital settings, addressing the increasing demand for effective respiratory support outside of healthcare facilities. Its primary goal is to provide high-quality heated humidification for both adult and pediatric patients, ensuring they receive effective respiratory care even after discharge from the hospital.
In September 2022, Sentec, a Switzerland-based provider of non-invasive monitoring solutions, completed the acquisition of Percussionaire for an undisclosed amount. This acquisition allowed Sentec to expand its respiratory monitoring product lines by incorporating Percussionaire's TRUE-IPV technology. Percussionaire, a US-based specialty ventilation company, specializes in the development, manufacturing, and marketing of products used in respiratory care, including flow ventilators.
Major companies operating in the high flow ventilators market include ResMed Inc., Hamilton Medical AG, Hersill SL, ZOLL Medical Corporation, Percussionaire Corporation, Vyaire Medical Inc., Koninklijke Philips NV, Medtronic Plc, Acutronic Medical Systems AG, Essex Industries Inc., Getinge AB, Dragerwerk AG & Co KGaA, Fisher & Paykel Healthcare Corporation Limited, Metan Co. Ltd., Intersurgical Ltd., Laerdal Medical AS, Magnamed Tecnologia Medica S.A., Medin Medical Innovations GmbH, Mercury Medical LLC, Mindray Medical International Limited, Nihon Kohden Corporation, O-Two Medical Technologies Inc., Pulmodyne Systems Inc., Sechrist Industries Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Smiths Group plc, SunMed Equipment Co. Ltd., Ventec Life Systems Inc., Weihai Strongmedical Sci-Tech. Co. Ltd., Westmed Inc.
North America was the largest region in the high flow ventilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global high flow ventilators market report during the forecast period. The regions covered in the high flow ventilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the high flow ventilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The high flow ventilators market consists of sales of high flow ventilator machines, humidification systems, nasal cannulas, breathing circuits, and filters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
High Flow Ventilators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on high flow ventilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for high flow ventilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high flow ventilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.